Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
Besser MJ, Shapira-Frommer R, Treves AJ, Zippel D, Itzhaki O, Schallmach E, Kubi A, Shalmon B, Hardan I, Catane R, Segal E, Markel G, Apter S, Nun AB, Kuchuk I, Shimoni A, Nagler A, Schachter J.
Besser MJ, et al. Among authors: hardan i.
J Immunother. 2009 May;32(4):415-23. doi: 10.1097/CJI.0b013e31819c8bda.
J Immunother. 2009.
PMID: 19342963
Clinical Trial.